Insights

Strategic expansion Target hospital networks and cancer centers with PROphet NSCLC as a first-line immunotherapy decision support tool. Given the large prospective trial across 40 sites and 1,700 patients, emphasize scalability and real-world impact to secure multi-site deployments.

Evidence-driven selling Leverage recent data presentations at WCLC and AACR around predictive performance and aging biomarkers to position PROphet NSCLC as a scientifically validated differentiator in precision oncology, appealing to clinicians and procurement teams seeking measurable outcomes.

AI and biomarker leadership Highlight the company’s AI-enabled proteomics platform and aging biomarker research to attract strategic partnerships with academic medical centers and payer collaborators interested in innovative biomarker development and cost-effective patient stratification.

Funding and credibility Utilize the current revenue range and recent AI health and oncology awards to bolster credibility in conversations with investors, hospital systems, and translational research networks seeking proven, award-winning technologies.

Cross-dell collaboration Identify opportunities to integrate PROphet with existing digital health and EHR ecosystems (e.g., Salesforce, OpenAI, AWS-backed data pipelines) to streamline clinician workflows, data capture, and reporting for broader adoption across care pathways.

Similar companies to OncoHost

OncoHost Tech Stack

OncoHost uses 8 technology products and services including iCIMS, Canva, Amazon Web Services, and more. Explore OncoHost's tech stack below.

Media & News

OncoHost's Email Address Formats

OncoHost uses at least 3 email formats:
OncoHost Email FormatsExamplePercentage
First@oncohost.comJohn@oncohost.com
71%
FirstL@oncohost.comJohnD@oncohost.com
27%
First.Last@oncohost.comJohn.Doe@oncohost.com
2%

Frequently Asked Questions

What is OncoHost's official website and social media links?

Minus sign iconPlus sign icon
OncoHost's official website is oncohost.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does OncoHost generate?

Minus sign iconPlus sign icon
As of October 2026, OncoHost's annual revenue is estimated to be $100M - $250M.

What is OncoHost's NAICS code?

Minus sign iconPlus sign icon
OncoHost's NAICS code is 62 - Health Care and Social Assistance.

How many employees does OncoHost have currently?

Minus sign iconPlus sign icon
As of October 2026, OncoHost has approximately 44 employees across 2 continents, including Asia and North America. Key team members include Ceo: O. S., Chief Financial Officer: M. H. and Chief Technology Officer: Y. E. Explore OncoHost's employee directory with LeadIQ.

What industry does OncoHost belong to?

Minus sign iconPlus sign icon
OncoHost operates in the Hospitals and Health Care industry.

What technology does OncoHost use?

Minus sign iconPlus sign icon
OncoHost's tech stack includes iCIMS, Canva, Amazon Web Services, WordPress, Salesforce, OpenAI, Pardot and Agentforce.

What is OncoHost's email format?

Minus sign iconPlus sign icon
OncoHost's email format typically follows the pattern of First@oncohost.com. Find more OncoHost email formats with LeadIQ.

How much funding has OncoHost raised to date?

Minus sign iconPlus sign icon
As of October 2026, OncoHost has raised $55M in funding. The last funding round occurred on May 15, 2025 for $2.8M.

When was OncoHost founded?

Minus sign iconPlus sign icon
OncoHost was founded in 2017.
OncoHost logo

OncoHost

Hospitals and Health CareHaifa, Israel11-50 Employees

OncoHost is a technology company in the hospitals and health care sector, based in Binyamina in the Haifa region of Israel. Its PROphet platform analyzes plasma proteomic patterns and, in non-small cell lung cancer, uses a single blood sample to guide first-line immunotherapy decisions. The NSCLC test provides clinicians with guidance on the initial treatment plan for each patient, supported by a large-scale prospective trial conducted at more than 40 sites with about 1,700 patients. The company serves oncologists and health care providers involved in precision diagnostics and biomarker development, focusing on improving patient outcomes in NSCLC. In 2026, OncoHost participated in AACR 2026 to present new research on proteomic aging biomarkers, illustrating ongoing activity in the field.

Section iconCompany Overview

NAICS Code
62 - Health Care and Social Assistance
Founded
2017
Employees
11-50

Section iconFunding & Financials

  • $55M

    OncoHost has raised a total of $55M of funding over 6 rounds. Their latest funding round was raised on May 15, 2025 in the amount of $2.8M as a Grant.

  • $100M - $250M

    OncoHost's revenue is estimated to be in the range of $100M - $250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.